InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,196.40
(
-0.42%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
87.03
(
0.58%
)
Bitcoin
62,596.52
(
-0.40%
)
Post# of 252455
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 832
Posts 119964
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 76302

Tuesday, 06/30/2009 10:35:11 AM

Tuesday, June 30, 2009 10:35:11 AM

Post# of 252455
Biolex completes enrollment of phase 2b Locteron trial in HCV:

http://finance.yahoo.com/news/Biolex-Therapeutics-Announces-iw-2990286556.html

It took Biolex only two months to enroll 100 patients, which is quite impressive. This trial will continue for another two years or so; however, as mentioned in #msg-37178496, Biolex plans to start phase-3 while the phase-2b trial is still running. The viral-load data at 12 weeks will be used to select the dose(s) to be tested in phase-3.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up